Description
EO 14398
Base award description: BREAST CANCEER INDEX (BCI)
Modification chain · 7 transactions
Each row is one published transaction. This action is the obligation recorded on that transaction — a change amount, as USAspending publishes it. Running total is computed by Glassbox VA as the cumulative sum of those amounts up to and including the row, so the last running total equals the award's net obligations shown above. The cumulative-total columns in the source files are not used: they are not frozen per modification.
- Base2022-03-15+$81,460= $81,460
- Mod P000012023-02-14+$81,460= $162,920
- Mod P000032024-02-09+$81,460= $244,380
- Mod P000042024-06-11-$150,701= $93,679
- Mod P000052025-02-05+$81,460= $175,139
- Mod P000062026-02-03+$81,460= $256,599
- Mod P000072026-07-20+$0= $256,599
| Transaction | Action date | This action (delta) | Running total | Description on this transaction |
|---|---|---|---|---|
| Base | 2022-03-15 | +$81,460 | $81,460 | BREAST CANCEER INDEX (BCI) |
| Mod P00001· EXERCISE AN OPTION | 2023-02-14 | +$81,460 | $162,920 | BREAST CANCEER INDEX (BCI) |
| Mod P00003· EXERCISE AN OPTION | 2024-02-09 | +$81,460 | $244,380 | BREAST CANCER INDEX (BCI) TESTING |
| Mod P00004· OTHER ADMINISTRATIVE ACTION | 2024-06-11 | −$150,701 | $93,679 | BREAST CANCER INDEX (BCI) TESTING - DE-OBLIGATE EXCESS FUNDS |
| Mod P00005· EXERCISE AN OPTION | 2025-02-05 | +$81,460 | $175,139 | BREAST CANCER INDEX (BCI) TESTING - DE-OBLIGATE EXCESS FUNDS |
| Mod P00006· EXERCISE AN OPTION | 2026-02-03 | +$81,460 | $256,599 | BREAST CANCER INDEX (BCI) TESTING |
| Mod P00007· SUPPLEMENTAL AGREEMENT FOR WORK WITHIN SCOPE | 2026-07-20 | +$0 | $256,599 | EO 14398 |
Related awards · 11
Awards are related by an explicit link in the data, stated for each group below — never by text similarity. Values are net obligations.
Other VA awards to the same recipient (UEI EL5WDRRT6895)
| Award | Office · PSC / listing | Net obligations | FY |
|---|---|---|---|
| 36C24622P0046 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · Q301 · REFERENCE LABORATORY TESTING | $15,800 | FY2022 |
| 36C24621P0993 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · Q301 · MEDICAL- LABORATORY TESTING | $7,900 | FY2021 |
| 36C24618P3218 | 246-NETWORK CONTRACTING OFFICE 6 (36C246) · 6515 · MEDICAL AND SURGICAL INSTRUMENTS, EQUIPMENT, AND SUPPLIES | $4,750 | FY2018 |
| VA24417P3861 | 244-NETWORK CONTRACT OFFICE 4 (36C244) · 6640 · LABORATORY EQUIPMENT AND SUPPLIES | $4,750 | FY2017 |
| VA26316P0604 | 618-MINNEAPOLIS VA MED CTR (00618) · Q301 · MEDICAL- LABORATORY TESTING | $5,400 | FY2016 |
| VA25015P1081 | 539-CINCINNATI · Q301 · MEDICAL- LABORATORY TESTING | $4,750 | FY2015 |
Other recipients under Q301 from 257-NETWORK CONTRACT OFFICE 17 (36C257) (most recent first)
| Award | Recipient | Office | Net obligations | FY |
|---|---|---|---|---|
| 36C25726N0415 | UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER OF SAN ANTONIO | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $27,000 | FY2026 |
| 36C25726N0419 | EXACT SCIENCES CORPORATION | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $127,174 | FY2026 |
| 36C25726N0422 | PROPATH SERVICES, LLC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $1,531,914 | FY2026 |
| 36C25726N0390 | NEOGENOMICS LABORATORIES, INC. | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $493,650 | FY2026 |
| 36C25726N0382 | BIODESIX, INC | 257-NETWORK CONTRACT OFFICE 17 (36C257) | $40,696 | FY2026 |
Cite as: Glassbox VA record view · VA contract (USAspending / FPDS) · CONT_AWD_36C25722P0340_3600_-NONE-_-NONE- · retrieved 2026-09-26.